The annual cost of managing chronic lymphocytic leukemia is projected to rise to $5.1 billion by 2025, up from $740,000 million in 2011.
The annual cost of managing chronic lymphocytic leukemia is projected to rise to $5.1 billion by 2025, up from $740,000 million in 2011.